Preparations of mouse interferon enhanced the expression of surface antigens of murine leukemia L 1210 cells, as determined by their alloantibodyabsorbing capacity. The factor responsible for the enhancement of surface antigen expression could not be dissociated from the antiviral activity of interferon by standard physicochemical means. Likewise, interferon did not increase the antibody-absorbing capacity of an interferonresistant subline of L 1210 cells. We conclude that interferon treatment of L 1210 cells is accompanied by modifications of the cell surface.
In addition to the well-known antiviral action (1) , interferon preparations also exert various biologic effects on cells (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . The nature of some of these effects suggested the possibility that interferon treatment might be associated with modifications of the cell surface. To test this hypothesis we have determined the effect of interferon on the surface antigen expression of mouse leukemia L 1210 cells by measuring their alloantibody-absorbing capacity. We report herein the results of these experiments.
MATERIALS AND METHODS
Cell Culture. Murine leukemia L 1210 cells (18) and an interferon-resistant subline, L 1210-R (19) , were cultivated in nonagitated suspension cultures in nutrient medium RPMI 1640 (Gibco), supplemented with 20% heat-inactivated horse serum and 1% i-glutamine (10 mmol/ml). EL4 cells (provided by Dr. K. T. Brunner) were cultivated in suspension cultures in the same nutrient medium, supplemented with 10% heat-inactivated calf serum, glutamine, asparagine (36 mg/liter) folic acid (6 mg/liter), and 5% trypticase soy broth.
Interferon and Control Preparations. Preparations of mouse interferon were obtained from the nutrient medium of monolayer cultures of MSV-Ia (20) , or C-243 cells (21) (provided through the courtesy of Dr. S. Baron) inoculated with Newcastle disease virus (NDV), and from brains of C57BI/6 mice inoculated intracerebrally with West Nile virus (22) . Preparations of rabbit interferon were obtained from the nutrient medium of monolayer cultures of RK 13 cells, inoculated with NDV. Control preparations consisted of the medium of uninoculated cell cultures or tissues of uninoculated animals. Preparation and semipurification of murine interferon have been described (15 (L 1210 and EL4 cells were maintained by serial passage in ascitic form in DBA/2 and C57B1/6 mice, respectively). The mice were bled 1 week after the last injection. The sera were decomplemented and stored at -20°. Isoantisera prepared by intraperitoneal injection of C57B1/6 mice with Balb/c splenic lymphocytes or intraperitoneal injection of Balb/c mice with C57B1/6 splenic lymphocytes were generously provided by Dr. J. P. Levy.
Labeling of Target Cells. For labeling with radioactive chromium (56Cr), 1 ml of a cell suspension (5 X 106 viable cells per ml) was incubated for 30 min at 370 with 0.1 ml of Na2CrO4 (2 mCi/ml, specific activity 400 Ci/mg of chromium, Centre d'Energie Atomique, France) (24) .
Cytotoxic Assay. 1 ml of 5"Cr-labeled target cells (2 X 105 cells per ml) was incubated with 0.1 ml of antiserum (for convenience this is referred to as a 1: 10 dilution) for 1 hr at 370; 0.9 ml of a 1:10 dilution of reconstituted, lyophilized guinea-pig serum was added. 0.25 ml of the reaction mixtures was then placed in disposable hemolysis tubes and incubated at 370 for 1 hr. For each reaction mixture, a minimum of three tubes was used. Assay of 51Cr released and the formula for calculation of the percentage of specific lysis have been presented (15) .
Absorption of Antisera. In experiments L 1210 or EL4 cells, kept in log-phase growth by daily dilution with fresh medium, were diluted to a concentration of 2 X 105 cells per ml. Interferon or control preparations were added, and the cells were incubated at 370 for the indicated periods of time. 1 X 107 Cells were sedimented by centrifugation, and the cell pellet was resuspended in 0.25 ml of an appropriate dilution of antiserum. After 1 hr of incubation at 370, the cells were again sedimented and the antiserum supernatant was harvested. 2-Fold dilutions of this supernatant were assayed for remaining complement-dependent cytotoxicity. cells were incubated with an appropriate antiserum dilution (corresponding to 1 cytotoxic unit, i.e., a 2-fold greater concentration than that which gave a 95% lytic endpoint). The factor in interferon preparations responsible for enhancement of antibody-absorbing capacity displayed the same physicochemical characteristics as interferon, and the activity could not be dissociated from interferon. Thus, procedures used to inactivate interferon (i.e., trypsin, sodium periodate, and heating) inactivated the antiviral activity of interferon and the factor that enhanced antibody-absorbing capacity. Furthermore (Fig. 1B) , untreated interferonresistant L 1210-R cells exhibited the same degree of absorbing capacity as interferon-sensitive L 1210 cells (Fig. 1A) cell multiplication. Both untreated and interferon-treated cells attained a plateau at 72 hr. The antibody-absorbing capacity of control cells was slightly greater at saturation density at 72 and 96 hr than in the logarithmic growth phase (Fig. 4B) . Interferon-treated L 1210 cells showed a marked increase in antibody-absorbing capacity at 24 hr, which was far greater than that observed for control cells at either 72 or 96 hr. The effect of interferon was even greater at 72 and 96 hr.
RESULTS
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L 1210 cells were seeded at a concentration of 2 X 106 cells per ml (saturation density) and at 2 X 105 cells per ml, and both cultures were incubated with 2500 units of interferon per ml for 24 hr. Interferon-treated cells seeded at saturation density displayed a greater antibody-absorbing capacity than interferon-treated cells in log-phase growth (cells seeded at 2 X 105 cells per ml), and both groups of interferon-treated cells had a greater antibody-absorbing capacity than control cells at saturation density.
Quantitative Estimation of Surface Antigen in InterferonTreated L 1210 Cells. To estimate quantitatively the expression of surface antigens on L 1210 cells, we performed a series of experiments with varying numbers of untreated and interferon-treated cells for absorption of antiserum against L 1210 from C57B1/6.
There was no difference in the antibody-absorbing capacity of control L 1210 cells after 24 and 48 hr of culture, and 4.8 X 105 cells were required to attain a 50% specific lysis at the antiserum dilution chosen (Fig. 5) (19) .
Our data do not permit us to state which surface antigens on L 1210 cells were increased by interferon treatment. The fact that interferon-treated L 1210 cells (H2-d) displayed an enhanced antibody-absorbing capacity for serum from C57B1/6 mice (H2-b) immunized with L 1210 cells, as well as for serum from C57B1/6 mice immunized with Balb/c (H2-d) splenic lymphocytes, suggests that we are measuring the expression of histocompatibility antigens on the surface of L 1210 cells. It is important to determine whether interferon enhances the expression of tumor-specific antigens in view of the marked inhibitory effect of interferon on viralinduced (26) , spontaneous (27) , and transplantable tumors (28) in mice.
Cikes and his coworkers (29) (30) (31) (32) found that the expression of surface antigens of a mouse leukemic cell line varied considerably during the growth cycle, but in general antigenic concentration increased as the growth rate declined. In agreement with their findings, antigen expression of L 1210 cells also increased as the cell population approached cell saturation density. Since interferon inhibits multiplication of L 1210 cells (9, 10, 19; Fig. 4A ) it is possible that the effect of interferon on surface antigen expression is secondary to its effect on cell division. However, interferon-treated cells displayed a far greater antibody-absorbing capacity than untreated cells even when the former were tested in logarithmic growth phase (Fig. 4B) . Furthermore, interferon enhanced the antibody-absorbing capacity of L 1210 cells even when (1) , inhibition of replication of other intracellular parasites (4, (6) (7) (8) , inhibition of cell division (3, 9, 11, 19) , decreased tumorigenicity and decreased colony-forming capacity of L 1210 cells in agarose (10) , enhanced phagocytosis by macrophages (12) , and cytotoxicity by sensitized lymphocytes (15) , enhanced production of specific proteins, such as interferon (2, 13) or aryl hydrocarbon hydroxylase (17) , and enhanced cellular sensitivity to the toxic effects of vaccinia virus (5, 14) and double-stranded polynucleotides (16) . It may be that a common mechanism of action underlies these different effects and that modification of the cell surface plays an important part in the expression of these effects.
